Rheumatic immune-related adverse events in patients on anti-PD-1 inhibitors: Fasciitis with myositis syndrome as a new complication of immunotherapy
- 10 August 2018
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 17 (10), 1040-1045
- https://doi.org/10.1016/j.autrev.2018.05.002
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Rheumatologic symptoms in oncologic patients on PD-1 inhibitorsSeminars in Arthritis and Rheumatism, 2018
- Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort studyAnnals Of The Rheumatic Diseases, 2017
- Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case seriesAnnals Of The Rheumatic Diseases, 2017
- Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatmentAnnals Of The Rheumatic Diseases, 2017
- Review: Immune‐Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of CancerArthritis & Rheumatology, 2017
- Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?Nature Reviews Rheumatology, 2016
- Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case ReportsPLOS ONE, 2016
- Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumabAnnals Of The Rheumatic Diseases, 2016
- Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysisBMC Medicine, 2015
- Arthritis and Tenosynovitis Associated With the Anti-PD1 Antibody Pembrolizumab in Metastatic MelanomaJournal of Immunotherapy, 2015